Answers are grounded in this paper and cite their sources.
Historical review highlights key spondyloarthritis advances across three decades of award-winning research, indicating the vital impact of sustained recognition on clinical rheumatology.
The city and casino of Wiesbaden, capital of the German state Hessen, have endowed the Carol Nachman Prize to promote research work in the field of rheumatology since 1972. The prize, endowed with 37,500 €, is the second highest medical award in Germany and serves to promote clinical, therapeutic, and experimental research work in the field of rheumatology. In June 2022, the 50-year anniversary was celebrated. In the symposium preceding the award ceremony, an overview was given on the significance of spondyloarthritis for the work of the awardees in the past 30 years. This overview has now been put together to inform the interested community of the work performed, including the opinion of the awardees regarding what they consider to be their most important contribution.
No takes yet. Share an insight, caveat, or question.
Braun et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: